Solstein Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $271K | Buy |
1,460
+350
| +32% | +$65K | 0.14% | 98 |
|
|
2025
Q1 | $233K | Hold |
1,110
| – | – | 0.14% | 86 |
|
|
2024
Q4 | $197K | Hold |
1,110
| – | – | 0.11% | 97 |
|
|
2024
Q3 | $219K | Hold |
1,110
| – | – | 0.12% | 97 |
|
|
2024
Q2 | $190K | Hold |
1,110
| – | – | 0.12% | 94 |
|
|
2024
Q1 | $202K | Sell |
1,110
-235
| -17% | -$42.8K | 0.14% | 90 |
|
|
2023
Q4 | $208K | Hold |
1,345
| – | – | 0.15% | 87 |
|
|
2023
Q3 | $200K | Hold |
1,345
| – | – | 0.17% | 84 |
|
|
2023
Q2 | $181K | Hold |
1,345
| – | – | 0.15% | 86 |
|
|
2023
Q1 | $214K | Hold |
1,345
| – | – | 0.19% | 84 |
|
|
2022
Q4 | $217K | Hold |
1,345
| – | – | 0.18% | 87 |
|
|
2022
Q3 | $181K | Sell |
1,345
-90
| -6% | -$12.1K | 0.16% | 87 |
|
|
2022
Q2 | $220K | Hold |
1,435
| – | – | 0.17% | 93 |
|
|
2022
Q1 | $233K | Hold |
1,435
| – | – | 0.15% | 103 |
|
|
2021
Q4 | $194K | Hold |
1,435
| – | – | 0.12% | 128 |
|
|
2021
Q3 | $155K | Hold |
1,435
| – | – | 0.09% | 147 |
|
|
2021
Q2 | $162K | Buy |
1,435
+374
| +35% | +$42.2K | 0.2% | 119 |
|
|
2021
Q1 | $115K | Buy |
+1,061
| New | +$115K | 0.16% | 145 |
|
|
2020
Q4 | – | Sell |
-935
| Closed | -$82K | – | 83 |
|
|
2020
Q3 | $82K | Hold |
935
| – | – | 0.18% | 99 |
|
|
2020
Q2 | $92K | Buy |
935
+112
| +14% | +$11K | 0.22% | 82 |
|
|
2020
Q1 | $63K | Buy |
823
+466
| +131% | +$35.7K | 0.24% | 67 |
|
|
2019
Q4 | $32K | Buy |
+357
| New | +$32K | 0.06% | 142 |
|